Live Breaking News & Updates on Lorena Castillo Campillo

Press release content from Business Wire. The AP news staff was not involved in its creation.
GenSight Biologics Announces Publication of Results from the REALITY LHON Natural History Study in the Journal Eye
May 3, 2021 GMT
Figure 1. Evolution of BCVA in ND4-LHON patients aged ≥ 15 at onset of vision loss (Graphic: Business Wire)
Figure 1. Evolution of BCVA in ND4-LHON patients aged ≥ 15 at onset of vision loss (Graphic: Business Wire)
PARIS (BUSINESS WIRE) May 3, 2021
Regulatory News:
Figure 1. Evolution of BCVA in ND4-LHON patients aged ≥ 15 at onset of vision loss (Graphic: Business Wire)
GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that ....

Wills Eye Hospital , United States , France General , United Kingdom , Thomas Jefferson University , City Of , Comunidad Autonoma De Cataluna , Neringa Jurkute , Magali Taiel , Clinica Neurologica , Markl Moster , Laure Blouin , Istituto Delle Scienze Neurologiche , Guillaume Van Renterghem , Nancyj Newman , Francescom Bandello , Los Angeles , Stephanie Leruez , Gensight Biologics , Valerio Carelli , Patrick Yu , Lorena Castillo Campillo , James Palmer , Rustum Karanjia , Catherine Vignal Clermont , Jeanene Timberlake ,